Eoin Treacy's view

I placed a call to the investor relations department of SolarWindow last week following the surge in its share price despite the fact it’s product is not commercially available. They offered two key pieces of information I believe subscribers might be interested in.

The first is they are still attempting to commercialise the technology and expect to be in manufacturing and marketing mode by the end of 2017 at the earliest. That would suggest the recent run-up in prices has little to do with expectations of imminent earnings growth. 

The second point related to what she said about the company looking for partners before beginning to manufacture. SolarWindow has a market cap of $102 million following a jump of 100% this year. Considering the challenge of manufacturing on a scale that would cement the company’s position as a major supplier, it is entirely possible it will be taken over or merge with a stronger competitor. That is of course assuming that the technology is capable of reaching commercial utility. 

The share pulled back sharply on Friday and will need to hold $3 area if medium-term scope for additional higher to lateral ranging is to be given the benefit of the doubt.